1. Home
  2. NNNN vs IMAX Comparison

NNNN vs IMAX Comparison

Compare NNNN & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • IMAX
  • Stock Information
  • Founded
  • NNNN 2021
  • IMAX 1967
  • Country
  • NNNN Germany
  • IMAX Canada
  • Employees
  • NNNN N/A
  • IMAX N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • IMAX
  • Sector
  • NNNN Health Care
  • IMAX
  • Exchange
  • NNNN Nasdaq
  • IMAX Nasdaq
  • Market Cap
  • NNNN 2.2B
  • IMAX 1.8B
  • IPO Year
  • NNNN 2025
  • IMAX 1994
  • Fundamental
  • Price
  • NNNN $23.92
  • IMAX $32.22
  • Analyst Decision
  • NNNN
  • IMAX Strong Buy
  • Analyst Count
  • NNNN 0
  • IMAX 9
  • Target Price
  • NNNN N/A
  • IMAX $35.78
  • AVG Volume (30 Days)
  • NNNN 76.5K
  • IMAX 1.0M
  • Earning Date
  • NNNN 11-07-2025
  • IMAX 10-23-2025
  • Dividend Yield
  • NNNN N/A
  • IMAX N/A
  • EPS Growth
  • NNNN N/A
  • IMAX 61.79
  • EPS
  • NNNN 0.06
  • IMAX 0.71
  • Revenue
  • NNNN $8,185,146.00
  • IMAX $377,677,000.00
  • Revenue This Year
  • NNNN N/A
  • IMAX $17.86
  • Revenue Next Year
  • NNNN N/A
  • IMAX $6.18
  • P/E Ratio
  • NNNN $442.46
  • IMAX $45.28
  • Revenue Growth
  • NNNN 21.95
  • IMAX 9.30
  • 52 Week Low
  • NNNN $5.18
  • IMAX $20.40
  • 52 Week High
  • NNNN $55.65
  • IMAX $34.14
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 35.64
  • IMAX 54.68
  • Support Level
  • NNNN $26.05
  • IMAX $31.44
  • Resistance Level
  • NNNN $30.65
  • IMAX $33.65
  • Average True Range (ATR)
  • NNNN 2.72
  • IMAX 1.11
  • MACD
  • NNNN -0.11
  • IMAX -0.10
  • Stochastic Oscillator
  • NNNN 19.80
  • IMAX 50.95

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About IMAX Imax Corporation

Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.

Share on Social Networks: